• Ward Sullivan Carmen C Department of Physiological Nursing, School of Nursing, University of California at San Francisco, San Francisco, CA, United States., Heather Leutwyler, Laura B Dunn, Bruce A Cooper, Steven M Paul, Yvette P Conley, Jon D Levine, and Christine A Miaskowski.
• Department of Physiological Nursing, School of Nursing, University of California at San Francisco, San Francisco, CA, United States.
• Eur J Oncol Nurs. 2017 Jun 1; 28: 122-132.

PurposeOne of the unanswered questions in symptom clusters research is whether the number and types of symptom clusters vary based on the dimension of the symptom experience used to create the clusters. Given that patients with breast cancer receiving chemotherapy (CTX), report between 10 and 32 concurrent symptoms and studies of symptom clusters in these patients are limited, the purpose of this study, in breast cancer patients undergoing CTX (n = 515), was to identify whether the number and types of symptom clusters differed based on whether symptom occurrence rates or symptom severity ratings were used to create the clusters.MethodsA modified version of the Memorial Symptom Assessment Scale was used to assess for the occurrence and severity of 38 symptoms, one week after the administration of CTX. Exploratory factor analysis was used to extract the symptom clusters.ResultsBoth the number and types of symptom clusters were similar using symptom occurrence rates or symptom severity ratings. Five symptom clusters were identified using symptom occurrence rates (i.e., psychological, hormonal, nutritional, gastrointestinal, epithelial). Six symptom clusters (i.e., psychological, hormonal, nutritional, gastrointestinal, epithelial, chemotherapy neuropathy) were identified using symptom severity ratings. Across the two dimensions, the specific symptoms within each of the symptom clusters were similar.ConclusionsIdentification of symptom clusters in patients with breast cancer may be useful in guiding symptom management interventions. Future studies are warranted to determine if symptom clusters remain stable over a cycle of CTX in patients with breast cancer.Copyright © 2017 Elsevier Ltd. All rights reserved.

25 keywords...

hide…